Boston Scientific
NYSE:BSXBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
102535 (CMM.V)
CVE:CMMCanabo Medical Inc, formerly Four River Ventures Ltd, is a Canada-based company, which is engaged in the provision of medical services and non-cannabinoid products for patients suffering from chronic pain and disabling illnesses through health clinics. The Company operates approximately 10 medical clinics across Canada. Its medical clinics are operated by qualified health care practitioners, independent medical marijuana evaluations for employers and insurers, and medical marijuana scientific research. The Company's subsidiary is Canabo Medical Corporation (CMC). Its CMClinics are located in Toronto, Barrie, Ottawa, Halifax, St. John's, Calgary, Edmonton, Stoney Creek, Hamilton and Burlington. Each clinic provides cannabinoid educators, who consult with patients to determine the proper treatment for their ailments using medical marijuana based on the medical documentation as prepared by the physician.
Gold Standard Ventures
NYSEAMERICAN:GSVGold Standard Ventures Corp., an exploration stage company, engages in the development of district-scale and other gold-bearing mineral resource properties in Nevada, the United States. Its flagship property is the Railroad-Pinion project covering an area of approximately 53,570 acres located in the Elko County, Nevada. The company was incorporated in 2004 and is headquartered in Vancouver, Canada. As of August 12, 2022, Gold Standard Ventures Corp operates as a subsidiary of Orla Mining Ltd.
Liberty Gold
TSE:LGDLiberty Gold Corp. engages in the acquisition, exploration, and development of mineral properties primarily in the United States and Türkiye. The company primarily explores for gold, as well as silver, lead, zinc, copper, and other precious and base metals. It holds interest in the Black Pine project located in Cassia County, southern Idaho; the Goldstrike project located in Washington County, southwest Utah; and the TV Tower gold-silver-copper property located in northwestern Türkiye. The company was formerly known as Pilot Gold Inc. and changed its name to Liberty Gold Corp. in May 2017. Liberty Gold Corp. was incorporated in 2010 and is based in Vancouver, Canada.